UbiVac Company
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Employee Number:
1-10
Headquarters:
Portland, Oregon, United States
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
2005
Last Funding Type:
Venture - Series Unknown
Investor Type:
For Profit
Total Funding:
$1.9M
Industry:
PharmTech